Scottish MS study aims to predict disease course years in advance

NCT ID NCT06001138

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: University of Edinburgh Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 440 people with relapsing-remitting multiple sclerosis for 5 to 10 years after their diagnosis. Researchers will use brain scans, lab tests, and genetic information to find patterns that predict how the disease will progress. The goal is to help doctors and patients better understand what to expect and tailor treatments accordingly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors predict how multiple sclerosis will progress in each person, leading to more personalized treatment plans.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test any new therapy. Results may take years and might not apply to all MS patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS

Contacts and locations

Locations

Aberdeen Clinical Research Facility Royal Cornhill Hospital

Aberdeen, AB25 2ZD, United Kingdom
Anne Rowling Regenerative Neurology Clinic

Edinburgh, EH16 4SB, United Kingdom
Centre for Health Sciences Raigmore Hospital

Inverness, IV2 3JH, United Kingdom
Dundee Clinical Research Centre Ninewells Hospital

Dundee, DD1 9SY, United Kingdom
Glasgow Clinical Research Facility Queen Elizabeth University Hospital

Glasgow, G51 4TF, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.